Can 23andMe have it all?
By Kelly Servick,
Science
| 09. 25. 2015
Untitled Document
How much do your eyes water when cutting onions? Does fresh cilantro taste like soap to you? Do you have stretch marks on your hips, thighs, or the backs of your arms? Have you ever been diagnosed with brain cancer?
Mail off your spit for a $99 genetic analysis from 23andMe, and you will get information about your ancestry, served up on a web account. You will also encounter a list of optional survey questions. A lot of survey questions. Some are quirky queries about your tastes and habits. Others are intimate probes into your experiences with disease and medicine.
For the team of more than 30 geneticists and statisticians behind one of the world's largest genetic biobanks, the surveys are bread and butter, allowing them to pin down links between DNA markers and people's health, appearance, and bodily idiosyncrasies. New medical and physiological connections have been incorporated into the $99 analysis, adding value for customers. The formula has enabled the Silicon Valley firm to outlast most of its competitors and become a poster child for the fledgling...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...